Cingulate CINGW Stock
Cingulate Price Chart
Cingulate CINGW Financial and Trading Overview
| Cingulate stock price | 0.03 USD |
| Previous Close | 0.04 USD |
| Open | 0.04 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.03 - 0.04 USD |
| 52 Week Range | 0.03 - 0.04 USD |
| Volume | 13.22K USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | -0.813 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.732 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CINGW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.025189394 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Cingulate Stock Price History
| Beta (5Y Monthly) | -0.813 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.04 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
CINGW Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 12.94M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.68% |
| Return on Equity (ttm) | -225.11% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -9735749 USD |
| EBITDA | -23658508 USD |
| Net Income Avi to Common (ttm) | -27909322 USD |
| Diluted EPS (ttm) | -1.732 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 25.89M USD |
| Total Cash Per Share (mrq) | 1.95 USD |
| Total Debt (mrq) | 7.43M USD |
| Total Debt/Equity (mrq) | 39.38 USD |
| Current Ratio (mrq) | 2.547 |
| Book Value Per Share (mrq) | 1.584 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19549860 USD |
| Levered Free Cash Flow (ttm) | -11919704 USD |
Profile of Cingulate
| Country | United States |
| State | KS |
| City | Kansas City |
| Address | 1901 West 47th Place |
| ZIP | 66205 |
| Phone | 913 942 2300 |
| Website | https://www.cingulate.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 14 |
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Q&A For Cingulate Stock
What is a current CINGW stock price?
Cingulate CINGW stock price today per share is 0.03 USD.
How to purchase Cingulate stock?
You can buy CINGW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cingulate?
The stock symbol or ticker of Cingulate is CINGW.
How many shares does Cingulate have in circulation?
The max supply of Cingulate shares is 0.
What is Cingulate Price to Earnings Ratio (PE Ratio)?
Cingulate PE Ratio is now.
What was Cingulate earnings per share over the trailing 12 months (TTM)?
Cingulate EPS is -1.732 USD over the trailing 12 months.